abstract |
The invention relates to triazine derivatives of formula (I): n n n n n n n n n n which are inhibitors of phosphodiesterase 2 or 10, useful in treating central nervous system diseases such as psychosis and also in treating, for example, obesity, type 2 diabetes, metabolic syndrome, glucose intolerance, and pain. |